Market Indices
Latest News
 |
Jasper Therapeutics, Inc. (JSPR) confirmed earnings release on March 05, 2026,...
March 4, 2026 JSPR 7.14% |
| ||
| ||
| ||
|
Price Targets
Kyle Mikson from Canaccord Genuity issued a price target of $1.00 for QSI on 2026-03-04 11:46:00.The adjusted price target was set to $1.00.At the time of the announcement,
March 4, 2026 QSI -3.76%
Heiko Ihle from H.C. Wainwright issued a price target of $30.75 for USGO on 2026-03-04 11:41:00.The adjusted price target was set to $30.75.At the time of the announcement,
March 4, 2026 USGO 1.22%
Mark Massaro from BTIG issued a price target of $7.00 for SOPH on 2026-03-03 19:23:00.The adjusted price target was set to $7.00.At the time of the announcement, SOPH...
March 3, 2026 SOPH 4.76%
Zhiger Kurmet from Loop Capital Markets issued a price target of $7.40 for ILPT on 2026-03-03 17:18:00.The adjusted price target was set to $7.40.At the time of the announcement,...
March 3, 2026 ILPT 1.31%
Laura Chico from Wedbush issued a price target of $12.00 for LRMR on 2026-03-03 14:30:00.The adjusted price target was set to $12.00.At the time of the announcement, LRMR...
March 3, 2026 LRMR -0.82%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| BW Babcock & Wilcox Enterpri | 11.82
45.88% | ||||||||||||||||||
| NOTV Inotiv, Inc. | 0.36
25.47% | ||||||||||||||||||
| GOSS Gossamer Bio, Inc. | 0.58
24.11% | ||||||||||||||||||
| QSIAW Quantum-Si incorporated | 0.18
22.45% | ||||||||||||||||||
| NBTX Nanobiotix S.A. | 35.77
16.97% | ||||||||||||||||||
| LPTX Leap Therapeutics, Inc. | 0.72
16.43% | ||||||||||||||||||
| RYAM Rayonier Advanced Materia | 10.89
16.22% | ||||||||||||||||||
| EJH E-Home Household Service | 0.80
15.48% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP 2.10%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE 11.22%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK 2.16%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN 2.89%